乳腺癌的基因研究進展_《中國普外基礎與臨床雜志》

作者：

幸天勇 ¹ , 楊金巧 ²

1. 川北醫學院附屬醫院外科(南充 637000)2. 華西醫科大學附屬第一醫院普外科;

關鍵詞：

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 幸天勇,楊金巧. 乳腺癌的基因研究進展. 中國普外基礎與臨床雜志, 1998, 5(5): 310-312. doi: 復制

1.	Noguchi M, Koyasaki N, Ohta N, et al. Cerb B2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph nodepositive breast cancer. Cancer, 1992; 69(13)∶2953.
2.	Berchuck A, Kamel A, Whitaker R, et al. Overexpression of Her2/new is associated with poor survival in advanced epithelial ovarian cancer. Cancer Research, 1990; 50(13)∶4087.
3.	Allred DC, Clark GM, Molina R, et al. Overexpression of Her2/new and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathology, 1992; 23(9)∶974.
4.	Porter PL, Garcia R, Moe R, et al. Cerb B2 oncogene protein in situ and invasive lobular breast neoplasia. Cancer, 1991; 68(2)∶331.
5.	Wright C, Nicholson S, Angus B, et al. Relationship Cerb B2 protein product expression and response to endocrine therapy in advanced breast cancer. British Journal of Cancer, 1992; 65(1)∶118.
6.	Vaughb JP, Stekler J, Demirdji S, et al. Inhibition of the Cerb B2 tyrisne kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisence oligonucleotides. Nucleic Acids Res, 1996; 24(3)∶4558.
7.	Visscher DW, Wallis T, Awussah S, et al. Evaluation of myc and chromosome δ copy number in breast carcinoma by interphase cytogenetics. Egenes Cgromosomes Cancer, 1997; 18(1)∶1.
8.	Lindlom A, Skoog L, Rotstein S, et al. Loss of Heterozygosity in familial breast carcinomas carcinogenesis. Cancer Research, 1993; 53(18)∶4356.
9.	Alan H. Signal transduction through small GTPasesa tale of two GAPs. Cell, 1992; 69(3)∶389.
10.	Weinbery RA. Oncogenes, antioncogenes, and the moleeular bases of multistep. Cancer Research, 1989; 49(11)∶3713.
11.	Cropps CS, Lidereau R, Leone A, et al. NME1 protein expression and loss of heterozygosity mutations in primary haman breast tumors. Journal of the National Cancer Institute, 1994; 86(15)∶1167.
12.	顧學文，陶曉鈺，陳月香. nm23基因在人乳腺癌中的表達及與淋巴結轉移的關系.實用癌癥雜志， 1997； 12(1)∶9.
13.	王川，張祥福，楊發端等. nm23在乳腺癌中的表達及其預后意義.福建醫學院學報， 1995； 29(3)∶236.
14.	Mudenda B, Green JA, Breen B, et al. The relationship between serus p53 autoantibodies and characteristics of human breast cancer. Br J Cancer, 1994; 69(6)∶1115.
15.	蔡永東，武正英，王樂.乳腺癌中抗癌基因p53突變及其臨床預后.實用癌癥雜志，1997; 12(2)∶117.
16.	Vander KK, Rookus MA, Peterse HL, et al. p53 protein overexpression in relation to risk factors for breast cancer. Eridemiol, 1996; 144(10)∶924.
17.	Silviastrini R, Veneronis, Diadone MG, et al. The bcl2 protein: a prognostic indicator strongly related to p53 protein in lymph nodenegative breast cancer patients. J Natl Cancer Inst, 1994; 84(13)∶499.
18.	Barbareschi M, Caffo O, Veronese S, et al. bcl2 and p53 expression in nodenegative breast carinoma: a study with longterm followup. Hum Pathol, 1996; 27(11)∶1149.
19.	Sierra A, Castellague X, Tortola S, et al. Apoptosis loss and bcl2 expression: key determinants of lymph nodemetastases in T1 breast cancer. Clin Canc Res, 1996; 2(11)∶1887.
20.	Lee WY, Jin YT, Tzeng CC. Reciprocal expression of bcl2 and p53 in breast ductal carcinoma. Anticancer Res, 1996; 16(50)∶A3007.

1. Noguchi M, Koyasaki N, Ohta N, et al. Cerb B2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph nodepositive breast cancer. Cancer, 1992; 69(13)∶2953.
2. Berchuck A, Kamel A, Whitaker R, et al. Overexpression of Her2/new is associated with poor survival in advanced epithelial ovarian cancer. Cancer Research, 1990; 50(13)∶4087.
3. Allred DC, Clark GM, Molina R, et al. Overexpression of Her2/new and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathology, 1992; 23(9)∶974.
4. Porter PL, Garcia R, Moe R, et al. Cerb B2 oncogene protein in situ and invasive lobular breast neoplasia. Cancer, 1991; 68(2)∶331.
5. Wright C, Nicholson S, Angus B, et al. Relationship Cerb B2 protein product expression and response to endocrine therapy in advanced breast cancer. British Journal of Cancer, 1992; 65(1)∶118.
6. Vaughb JP, Stekler J, Demirdji S, et al. Inhibition of the Cerb B2 tyrisne kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisence oligonucleotides. Nucleic Acids Res, 1996; 24(3)∶4558.
7. Visscher DW, Wallis T, Awussah S, et al. Evaluation of myc and chromosome δ copy number in breast carcinoma by interphase cytogenetics. Egenes Cgromosomes Cancer, 1997; 18(1)∶1.
8. Lindlom A, Skoog L, Rotstein S, et al. Loss of Heterozygosity in familial breast carcinomas carcinogenesis. Cancer Research, 1993; 53(18)∶4356.
9. Alan H. Signal transduction through small GTPasesa tale of two GAPs. Cell, 1992; 69(3)∶389.
10. Weinbery RA. Oncogenes, antioncogenes, and the moleeular bases of multistep. Cancer Research, 1989; 49(11)∶3713.
11. Cropps CS, Lidereau R, Leone A, et al. NME1 protein expression and loss of heterozygosity mutations in primary haman breast tumors. Journal of the National Cancer Institute, 1994; 86(15)∶1167.
12. 顧學文，陶曉鈺，陳月香. nm23基因在人乳腺癌中的表達及與淋巴結轉移的關系.實用癌癥雜志， 1997； 12(1)∶9.
13. 王川，張祥福，楊發端等. nm23在乳腺癌中的表達及其預后意義.福建醫學院學報， 1995； 29(3)∶236.
14. Mudenda B, Green JA, Breen B, et al. The relationship between serus p53 autoantibodies and characteristics of human breast cancer. Br J Cancer, 1994; 69(6)∶1115.
15. 蔡永東，武正英，王樂.乳腺癌中抗癌基因p53突變及其臨床預后.實用癌癥雜志，1997; 12(2)∶117.
16. Vander KK, Rookus MA, Peterse HL, et al. p53 protein overexpression in relation to risk factors for breast cancer. Eridemiol, 1996; 144(10)∶924.
17. Silviastrini R, Veneronis, Diadone MG, et al. The bcl2 protein: a prognostic indicator strongly related to p53 protein in lymph nodenegative breast cancer patients. J Natl Cancer Inst, 1994; 84(13)∶499.
18. Barbareschi M, Caffo O, Veronese S, et al. bcl2 and p53 expression in nodenegative breast carinoma: a study with longterm followup. Hum Pathol, 1996; 27(11)∶1149.
19. Sierra A, Castellague X, Tortola S, et al. Apoptosis loss and bcl2 expression: key determinants of lymph nodemetastases in T1 breast cancer. Clin Canc Res, 1996; 2(11)∶1887.
20. Lee WY, Jin YT, Tzeng CC. Reciprocal expression of bcl2 and p53 in breast ductal carcinoma. Anticancer Res, 1996; 16(50)∶A3007.

《中國普外基礎與臨床雜志》

乳腺癌的基因研究進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

乳腺癌的基因研究進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料